Brain, Pain, Opioids. John Hart, DO
|
|
- Nancy Greene
- 5 years ago
- Views:
Transcription
1 Brain, Pain, Opioids CHANGE John Hart, DO
2 4 % Rule
3
4 1 UDS Pain score Contract & PMP Ask about addiction Ak Ask about tfunction As long as function increases, there is no upper limit to opioid
5 UDS Pain score Contract & PMP Ask about addiction Ask about function 2 Upper limit 120 mg Morphine Equivilent
6 3 UDS Pain score Contract & PMP Ask about addiction Ask about function Upper limit mg ME
7 UDS Pi Pain score Contract & PMP Ask about addiction Ask about function 1 As long as function increases, there is no upper limit
8 2 UDS Pain score Contract & PMP Ask about addiction Ask about function Upper limit 120 mg ME
9 UDS Pain score Contract & PMP Ask about addiction Ask about function Upper limit it mg ME
10
11 How to increase Long Term Disability x 2 Write one opioid script for over 7 days Or Write 2 opioid prescriptions Franklin et al Spine 2008
12 How to keep your patients on opioids for 5 years. (60 office visits) Patients on Chronic Opioid Therapy for 90 days 60% will be on opioids at 5 years. Martin et al 2011 Gen Int Med 2011;26:450 7
13 Previous focus: Decrease pain, increase function Safety New focus: Don t start Don t continue
14 Give patient proper information at the start. t Chronic Opioid Therapy relieves only about 30 % of a persons pain. Do not expect more.
15
16 SIMPLE GUIDELINES Post surgery 6 weeks- stop opioids Avoid sub acute Don t exceed 90 days
17 New Guidelines American Academy of Neurology 2014 Do NOT use COT for: 1. Chronic low back pain 2. Headaches 3. Fibromyalgia Dose mg
18 RECCOMENDATIONS O 50 mg ACOEM (American College of Occupational and Environmental Medicine) 50 mg - Virginia Garcia Health Care
19
20 Who Overdoses? Over 100 mg = OD rate is x 9 ½ of OD is from intermittent or low dose opioids id
21 Summary Patients not on Narcotics Don t use for Headache, Low Back Pain & Fibromyalgia When COT is used, tell patient to only expect 30 % relief Stay below 50 mg If using long acting opioids, avoid use of breakthrough Rx
22
23 Why do we have all of these problems? What do opioids do to the brain? What didn t the drug salesperson tell us?
24 Let s look at this from a Laboratory viewpoint
25 Before entering the lab, we must understand one thing. The brain doesn t care if oxycodone comes from a prescription or the street. The chemical changes in the brain are the same.
26 Dopamine D2 Receptors are Lower DA DA Cocaine Meth DA DA DA DA DA DA DA DA DA DA Reward Circuits Non-Drug Abuser DA DA Alcohol DA DA DA DA Heroin control User Reward Circuits Drug Abuser Adapted from Volkow et al., Neurobiology of Learning and Memory 78: , 2002.
27 Effects of Drugs on Dopamine Release % of Basal Re elease Accumbens AMPHETAMINE DA DOPAC HVA hr Time After Amphetamine % of Basal Rele ease Accumbens COCAINE DA DOPAC HVA hr Time After Cocaine % of Basal Release NICOTINE Accumbens Caudate % of Basal Re elease Accumbens MORPHINE Dose (mg/kg) hr Time After Nicotine hr Time After Morphine Di Chiara and Imperato, PNAS, 1988
28 What do these brain look like? Normal Opioid Exposed Loss of dopamine Receptors
29 Tolerance is dopamine receptor loss BRAIN DAMAGE which in certain people is permanent and irretrievable.
30 So what? Does reduced dopamine activity affect behavior?
31 Effects of Tx with an Adenovirus Carrying a DA D2 Receptor Gene into NAc in DA D2 Receptors Overexpression of DA D2 receptors reduces alcohol self-administration Change in D2R Percent 60 R Vector Rp < st D2 p < R Vector 2nd D2 p < p < p < p < p < p < Thanos, PK et al., J Neurochem, 78, pp , Time (days) Null Vector p < p < 0.001
32 Decreases in Metabolism in Anterior Cingulate Gyrus Orbito Frontal Cortex (OFC) Impulsivity Compulsive Drug Intake control cocaine abuser ACG = rational cognitive, decision making
33 Normal Exposed Brain High Control user The loss of receptors in the orbital frontal cortex reduces self inhibition. Why can t they followthe Pain Contract?. Low Sources: From the laboratories of Drs. N. Volkow and H. Schelbert
34 Effects of a Social Stressor on Brain DA D2 Receptors and Propensity to Administer Drugs Individually Housed Becomes Dominant No longer stressed Group Housed Dominant 50 Subordinate * * Becomes Subordinate Stress remains 10 0 S Cocaine (mg/kg/injection) Morgan, D. et al. Nature Neuroscience, 5: , 174, 2002.
35 Low Dopamine People EAT Opioids
36 Wouldn t it be nice to know who has low dopamine receptors?
37 Know who has low dopamine and you may have a view of the future!
38 Ask 4 simple questions
39 1. Previous history of drugs or alcohol?
40 2. Genetics How Important? t? 50%
41 The Development of Addiction: Genetics 2. Details of Genetics: Parents, Grand Parents, Siblings? Inheritability has been found to range from 40-60% Some variability between: gender and substances Specifically: 4-fold increased risk in 1st degree relatives 4-fold increased risk also in adopted away children
42 Selective Breeding Originating gpopulation (a genetically diverse sample) 1 st selected generation 2 nd selected generation 3 rd selected generation
43 3. At what age did they start smoking?
44 Smoking before e brain reaches maturity results in: Increased use of substances of abuse 4-12 times normal population. If one pack/day before age 16= 100 fld fold increase in cocaine
45 Years of Use 4. How many years and amount of opioid exposure to the brain? Amount of Use Amount of Receptor Loss
46 4 simple questions 1. Previous personal history 2. Genetics 3. Age start smoking 4. Exposure time & amount
47 Forget guidelines by committee And the laboratory. Suggestions for practice.
48 Tell patients THERE HAVE BEEN MAJOR CHANGES IN OPIOID TREATMENT.
49 The new recommendations are Not to use chronic opioids for Low Back Pain, Headache & Fibromyalgia Chronic use of opioids will only help with 30% of their pain. The other 70 % is up to them.
50 Chronic opioids are neurotoxic For the dopamine system.
51 Chronic Opioid Therapy Kappa Receptors Pain and Depression
52 My patients are already on opioids. Now what do I do? Change the dialog Explain about receptor loss
53 Presently on Opioids? Look for a lever, an excuse to start lowering the opioids. This may be an increase in pain, an increase in depression or any side effect that allows you to open a dialogue concerning possible receptor damage.
54 How to get patient s buy in. For their long term health, would they consider a small reduction? This is for their hibrain tissue and In case they get injured and need more opioid in the future
55 Reasonable goals ( The world is not perfect) If above 50 mg, make 50 mg the goal If below 50 mg, make mg the goal If not on opioids, don t continue past the acute stage when the first opioid is given for acute injury set the end date
56 Rule of Thumb 20 to 50 mg is the most for pain Anything above that is due to receptor damage. I want to help you, but I cannot cause further receptor damage.
57 How to Taper Narcotics mg Taper Reduce by 10% per time unit (3 days, weeks or month) Try reducing breakthrough h first. (Produces dopamine spike)
58 2 scripts trick #1 todays dosage (first script) #2 reduced dosage (second script) If aggressive reduction, try clonidine patch TTS 1-2 or gabapentin
59 How to Lower Narcotics 70 mg and higher, if taper is not working: Use Buprenorphine/Naloxone (Suboxone) For Pain & Opioid Dependence combined. (Not discussed at this session)
60 Why do we not start COT and why do we want to reduce the opioid load? Because we care about the long term health of our patient s brain receptors and we do not want to trade short term happiness for long term damage.
61 4 simple questions 1. Previous personal history 2. Genetics 3. Age start smoking 4. Exposure time & amount
62 The new recommendations are NOT to use chronic opioids for Low Back Pain, Headache & Fibromyalgia Chronic use of opioids will only help with 30% of their pain. The other 70 % is up to them.
63 Change can Be Good
64 Additional Resources Available Physicians for responsible opioid prescribing PROP org/resources/ WA Guidelines ACOEM Guidelines (4%)
Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO
Understanding Addiction and Its Impact on the Brain SDSMA Webinar Matthew Stanley, DO Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: Alcohol: Tobacco: $181 billion/year
More informationThe Biology of Addiction
The Biology of Addiction Risk factors for addiction: Biological/Genetic Family history of addiction Being male Having mental illness Exposure to substances in utero * The genes that people are born with
More informationThe Neurobiology of Drug Addiction
The Neurobiology of Drug Addiction Glen R. Hanson, Ph.D., D.D.S. Director, Utah Addiction Center Professor of Pharmacology and Toxicology, U of U Senior Advisor, NIDA Drug Abuse and Addiction are Among
More informationThe Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison
The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison Attitudes about addiction and recovery throughout history Disease?
More informationThe Role of NEUROIMAGING In Diagnostic and Clinical Practice
The Role of NEUROIMAGING In Diagnostic and Clinical Practice ADHD Schizophrenia Autism Addiction Altzheimer s Disease Nora D. Volkow, M.D. Director National Institute on Drug Abuse National Institutes
More informationNATURE VS NURTURE. Heroin & Opioid Addictions Impact on Health & Wellbeing of Individuals, Families & Populations OVERVIEW OF PRESENTATION
Heroin & Opioid Addictions Impact on Health & Wellbeing of Individuals, Families & Populations OVERVIEW OF PRESENTATION Review of biology of addiction The Opioid Epidemic Impact on the individual Impact
More informationAddiction as a Neuropsychiatric Medical Condition
Addiction as a Neuropsychiatric Medical Condition Wilson M. Compton, M.D., M.P.E. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse 5 November 2009 Summary
More informationNeurobiological Advances in Addiction Science: Implications For Treatment Nora D. Volkow, M.D. Director
Neurobiological Advances in Addiction Science: Implications For Treatment Nora D. Volkow, M.D. Director @NInews Concentration ) Dopamine (nm) Drugs and Natural Rewards ACTIVATE Dopamine in Reward Regions
More informationThe Science of Addiction: Prescription Opioid Abuse. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse
The Science of Addiction: Prescription Opioid Abuse Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse Key Points: 1. Prescription opioid abuse is a major problem in USA
More informationThe Neurobiology of Addiction
The Neurobiology of Addiction Jodi Gilman, Ph.D. Center for Addiction Medicine Massachusetts General Hospital Associate Professor, Department of Psychiatry Harvard Medical School What is Addiction? commonly
More informationNeurobiological Advances in Addiction Science: Implications For Prevention and Treatment Nora D. Volkow, M.D. Director
Neurobiological Advances in Addiction Science: Implications For Prevention and Treatment Nora D. Volkow, M.D. Director @NIDAnews Drugs and Natural Rewards ACTIVATE Dopamine in Reward Regions % of Basal
More informationAddiction 101. Steve Hanson - Associate Commissioner NYS OASAS
Addiction 101 Steve Hanson - Associate Commissioner NYS OASAS After lunch Psychopharmacology Lecture Basic Questions Why do people do drugs? Why can t/ won t some people stop? Realities 1. People like
More informationThe Science of Addiction
The Science of Addiction Immersion Training in Addiction Medicine Program 2018 April 23, 2018 Daniel P. Alford, MD, MPH Professor of Medicine Associate Dean, Continuing Medical Education Director, Clinical
More informationEighth Edition. Part I: Current Science of Addiction, Relapse & Recovery: Dispelling The Stigmas
Eighth Edition Part I: Current Science of Addiction, Relapse & Recovery: Dispelling The Stigmas 1 < < < Evolution of our Human Brain: Spinal Cord to Diencephalon to Mammalian-Meso Cortex to Neo Cortex
More informationine) on (% Baseli Concentratio DA C
Chemical Dependency Relapse Pathways Relapse Prevention Medications Understanding the how, why, where and when. Acknowledgements La Hacienda Treatment Center American Society of Addiction Medicine National
More informationMedical Interventions for Addiction in Primary Care Settings. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine
Medical Interventions for Addiction in Primary Care Settings R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine March 23, 2010 NIH Consensus on Drug Treatment Drug Addiction
More informationBrain Health and Opioid Abuse
2018 Statewide Tribal Opioid Summit Brain Health and Opioid Abuse Healing From Opiate Addiction Requires Comprehensive Approaches Psychological, Socio-Cultural, and Biological Donald R. Vereen, Jr., M.D.,
More informationNeurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP
Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the
More informationUpdate on Medications for Tobacco Cessation
Update on Medications for Tobacco Cessation Marc Fishman MD Johns Hopkins University Dept of Psychiatry Maryland Treatment Centers Baltimore MD MDQuit Best Practices Conference Jan 2013 Nicotine Addiction
More informationThe Neurobiology of Street Drugs. Joe Gilboy PA-C Hoag Hospital Emergency Department Irvine, CA. Neuroplasticity. Question #1
The Neurobiology of Street Drugs Joe Gilboy PA-C Hoag Hospital Emergency Department Irvine, CA Question #1 Neuroplasticity is the new field of neurobiology that is based upon which of the following : 1.
More informationThe Human Animal Drugs of Plant Origin
The Human Animal Drugs of Plant Origin Plant Secondary Compounds The Spice of Life Cultural Use of Spices Spice Use by Region 1 Silurian Land Plants History of Insect Damage 416-447 MYA Colonization of
More informationOPIOID USE DISORDER (OUD) TREATMENT IN A PATIENT CENTERED HEALTH CENTER
OPIOID USE DISORDER (OUD) TREATMENT IN A PATIENT CENTERED HEALTH CENTER Ed Johnson M.Ed., MAC, LPC, CCS Associate Director, Training & Technical Assistance Southeast Addiction Technology Transfer Center
More informationThe Science of Drug Addiction: Implications for Clinical Practice
The Science of Drug Addiction: Implications for Clinical Practice Jack B. Stein, Ph.D. Director Office of Science Policy and Communications National Institute on Drug Abuse National Institutes of Health
More information590,000 deaths can be attributed to an addictive substance in some way
Mortality and morbidity attributable to use of addictive substances in the United States. The Association of American Physicians from 1999 60 million tobacco smokers in the U.S. 14 million dependent on
More informationThe Neuroscience of Addiction: A mini-review
The Neuroscience of Addiction: A mini-review Jim Morrill, MD, PhD MGH Charlestown HealthCare Center Massachusetts General Hospital Disclosures Neither I nor my spouse/partner has a relevant financial relationship
More informationNeurobiology of Addiction
Neurobiology of Addiction Cindy Miner, Ph.D. Deputy Director Office of Science Policy and Communications National Institute on Drug Abuse National Institutes of Health Department of Health and Human Services
More informationImplementing Adolescent Recovery Supports & Developing Resources in our Communities
Implementing Adolescent Recovery Supports & Developing Resources in our Communities Reclaiming Futures Thursday, September 27th 11am PDT / 2pm EDT Click to edit Master title style Common Myths About Drug
More informationThe Opioid Epidemic and Youth Prescription Drug Abuse. Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth
The Opioid Epidemic and Youth Prescription Drug Abuse Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth Disclosures: I have no relevant financial relationships with the manufacturer(s)
More informationAddressing Opiate Abuse
Addressing Opiate Abuse William B. Lawson, MD, PhD, DLFAPA Associate Dean of Health Disparities University of Texas at Austin Dell Medical School william.lawson@austin.utexas.edu Opioids Medications that
More informationNeurobiology of Addiction
Neurobiology of Addiction Tiffany Love, Ph.D. Department of Psychiatry The University of Utah What is Addiction? Addiction is a chronic, relapsing, and treatable brain disorder. Compulsive drug seeking
More informationteen drug use Percent of 12th-graders Who Used A Substance in the Past Month (Type of Drug & Prevalence): 13% 33% 11% 23%
teen drug use As kids get older, they often start to question the life lessons they hear from parents and teachers. They become more heavily influenced by the things they see on TV, the Internet and social
More informationListen & Hear 4Lo
Mark Lim M.D FASAM Medical Director NorthLakes Community Clinic Recovery Program Board Certified in Family Medicine Board Certified in Addiction Medicine mlim@northlakesclinic.org 7156852200 Listen & Hear
More informationOPIATE ABUSE WEBCAST October 16, 2014
OPIATE ABUSE WEBCAST October 16, 2014 TABLE OF CONTENTS Program Graphics Pg 1 References 23 Level II Evaluation 26 Questions I Have form 27 Learning Objectives: After participating in today s training,
More informationBrain Imaging studies in substance abuse. Jody Tanabe, MD University of Colorado Denver
Brain Imaging studies in substance abuse Jody Tanabe, MD University of Colorado Denver NRSC January 28, 2010 Costs: Health, Crime, Productivity Costs in billions of dollars (2002) $400 $350 $400B legal
More informationsome things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment
some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment This booklet was created to help you learn about opioids. You probably have lots
More informationUnderstanding Drug Abuse and Addiction. Steve Hanson - Associate Commissioner NYS OASAS
Understanding Drug Abuse and Addiction Steve Hanson - Associate Commissioner NYS OASAS Basic Questions Why do people do drugs? Why can t/ won t some people stop? Realities 1. People like Drugs. 2. We all
More informationBrain Reward Pathway and Addiction
STO-131 Brain Reward Pathway and Addiction Part 1: Is Addictive? Medical Report Ray is feeling horrible. He is very depressed and nervous. He has a headache and nausea, and he is having trouble sleeping.
More informationOpioid Analgesics: Responsible Prescribing in the Midst of an Epidemic
Opioid Analgesics: Responsible Prescribing in the Midst of an Epidemic Lucas Buffaloe, MD Associate Professor of Clinical Family and Community Medicine University of Missouri Health Care Goals for today
More informationShining a Light on MEDs Understanding morphine equivalent dose
Shining a Light on MEDs Understanding morphine equivalent dose In the workers compensation industry, 60.2 percent of claimants utilize opioid analgesics for the treatment of pain caused by a workplace
More informationStriking a Balance: a provider perspective.
Striking a Balance: a provider perspective kpfeifer@chcf.org Beth s story 38 years old, erratically employed Counseling doesn t help Chronic low back pain after car accident 8 Vicodin/day grew to 180 mg
More informationThe Science of Drug Addiction: Implications for Clinical Practice
The Science of Drug Addiction: Implications for Clinical Practice Jack B. Stein, Ph.D. Director Office of Science Policy and Communications National Institute on Drug Abuse National Institutes of Health
More informationDrugs, Brain and Behavior
Drugs, Brain and Behavior The Neuroscience of Addiction and Trauma Libby Stuyt, MD NADA Training September 2015 Why Do People Try Alcohol, Tobacco, or Drugs in the First Place? Parents/family members use
More informationProlonged Use Changes the brain in Fundamental and Long Lasting Ways. People like Drugs. We all like things faster and easier.
Understanding Drug Abuse and Addiction Basic Questions Steve Hanson Why do people do drugs? Why can t/ won t some people stop? People like Drugs. We all like things faster and easier. Realities How Drugs
More informationFLAME TEEN HANDOUT Week 9 - Addiction
FLAME TEEN HANDOUT Week 9 - Addiction Notes from the large group presentation: What was your overall reaction of the presentation? What did the presenter say about addition? What did you agree with? Was
More informationPeople like Drugs. We all like things faster and easier.
Understanding Drug Abuse and Addiction Basic Questions Steve Hanson Why do people do drugs? Why can t/ won t some people stop? People like Drugs. We all like things faster and easier. Realities How Drugs
More informationTop 10 narcotic pain pills
Top 10 narcotic pain pills Click to go to the item or just scroll down the page. Doctors Respond to FDA Panel Recommendations FDA Considers Banning Popular Prescription Pain Medications and. Top 10 Natural
More informationEffects of Drugs on the Brain and Behavior in Adolescents
Effects of Drugs on the Brain and Behavior in Adolescents Lucas Moore, LCSW, SAC-IT Adolescent Substance Abuse Treatment Coordinator July 20, 2015 Wisconsin Department of Health Services Today What would
More informationThe Science of Addiction
This is the property of 2016 CRIT/FIT. Permission is required to duplicate. The Science of Addiction CRIT/FIT 2016 April 24-27, 2016 Daniel P. Alford, MD, MPH Associate Professor of Medicine Assistant
More informationStep 1: Go to this web address
Name: Period Drugs Webquest Step 1: Go to this web address http://learn.genetics.utah.edu/content/addiction/ The New Science of Addictions: Genetics and the Brain Drug addiction is a chronic disease characterized
More information4/28/2016. You don t need to remember. ASAM Definition of Addiction. ASAM Definition
Adolescent Opioid Addiction: Awareness, Understanding & How to Respond Mark Publicker, MD FASAM Diplomate, American Board of Addiction Medicine You don t need to remember Increases neuronal dendritic branching
More informationten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment
ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment This booklet was created to help you learn about tapering. You probably have lots
More informationUnderstanding Alcohol And Other Drugs Of Abuse
Understanding Alcohol And Other Drugs Of Abuse Wilkie A. Wilson, Ph.D. DukeLEARN www.dukelearn.com Duke University Medical Center 1 We teach people to respect their hearts... Exercise Eat good food Reduce
More informationINJECT PERCOCET
INJECT PERCOCET 10 325 Inject Percocet 10 325 And futures percocet molly The percocet time 3 tylenol same combination of and Percocet off molly effects of wear the and Percocet relief for pain 2 last week
More informationA Guide to Help You Reduce and Stop Using Tobacco
Let s Talk Tobacco A Guide to Help You Reduce and Stop Using Tobacco Congratulations for taking this first step towards a healthier you! 1-866-710-QUIT (7848) albertaquits.ca It can be hard to stop using
More informationFentanyl, Opioid Overdose and Naloxone
Fentanyl, Opioid Overdose and Naloxone Opioid Agonist Therapy Conference Saskatoon, SK April, 2016 Declaration No conflict of interest. Consultant in Addiction Medicine, SHR. Chair, College of Physicians
More informationOregon ACEP Opioid Prescribing Guidelines. Why are we talking about this?
Oregon ACEP Opioid Prescribing Guidelines Hans Notenboom, M.D. FACEP Current OCEP President Why are we talking about this? Current opioid epidemic 33,000 deaths over half with Rx meds Since 1999 number
More informationTobacco Dependence: Assessment and Treatment. Douglas Arenberg
Tobacco Dependence: Assessment and Treatment Douglas Arenberg Disclosure MDCH Grant Funds to improve tobacco cessation service in the Michigan Medicine Health System Past paid service Consultant/Advisory
More informationPrescription Opioid Addiction
CSAM-SCAM Fundamentals Prescription Opioid Addiction Presentation provided by Meldon Kahan, MD Family & Community Medicine University of Toronto Conflict of interest statement I received funds from Rickett
More informationChanging Prescribing Practices In Dentistry
Changing Prescribing Practices In Dentistry Paul J. Desjardins, D.M.D., Ph.D. Adjunct Clinical Professor, Rutgers School of Dental Medicine Visiting Professor, Tufts University, School of Dental Medicine
More informationOpioid Abuse in Iowa Rx to Heroin. Iowa Governor s Office of Drug Control Policy January 2016
1 Opioid Abuse in Iowa Rx to Heroin Iowa Governor s Office of Drug Control Policy January 2016 Why Is This Important? 2 3 National Rx Painkiller Trends CDC, 2013 4 National Rx-Heroin Trends NIH, 2015 5
More informationMANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER
MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St. Peter s Health Partners Grand Rounds October 11, 2017 Disclosures One
More informationRecognizing Narcotic Abuse and Addiction and Helping Those With It
Recognizing Narcotic Abuse and Addiction and Helping Those With It Michael McNett, MD Medical Director for Chronic Pain Member, WI Med Society Opioid Subcommittee Ancient History 1995: OxyContin approved
More informationScience of Addiction Script Segment Two
Science of Addiction Script Segment Two TIME SHOT / TITLE 1. 00:00 2. 00:12 On camera DESCRIPTION ANIMATED OPEN NEVES ON CAMERA: HI, I M ANTONIO NEVES FOR THE.NEWS. 3. 00:32 On camera 4. 00:41 Voice over
More informationMedication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.
Slide #1 Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale AIDS Program Medical Director South Central Rehabilitation
More informationTHE CHRONIC DISEASE OF ADDICTION. J.A. Samander, M.D.
THE CHRONIC DISEASE OF ADDICTION J.A. Samander, M.D. OBJECTIVES Review of chronic, relapsing model of addiction Comparison with other chronic diseases Lessons from patients Addiction 24.6 million adults
More informationBest Practices in Prescribing Opioids for Chronic Non-cancer Pain
Best Practices in Prescribing Opioids for Chronic Non-cancer Pain Disclosures S C O T T S T E I G E R, M D, F A C P, D A B A M A S S I S T A N T C L I N I C A L P R O F E S S O R D I V I S I O N O F G
More informationMOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre
1 MOLECULAR BIOLOGY OF DRUG ADDICTION Sylvane Desrivières, SGDP Centre Reward 2 Humans, as well as other organisms engage in behaviours that are rewarding The pleasurable feelings provide positive reinforcement
More informationOpioid Epidemic Update
Opioid Epidemic Update - 2018 Talal Khan MD Addiction Psychiatrist Pine Rest What are Opioids? Opiates are alkaloid compounds naturally found in the opium Poppy plant. Papaver somniferum The psychoactive
More informationClinical contracts. Dr. Johan Wouterloot Prescribers Course April 28, 2017
Clinical contracts Dr. Johan Wouterloot Prescribers Course April 28, 2017 Why? Ameliorates power imbalance States a goal for the agreed upon activity Allows for contingency management to keep behaviour
More informationHarm reduction for drug users
In Northern Ireland, 3 out of 4 drug-related deaths involve more than one drug or a combination of one or more drugs and alcohol. In many cases, prescription drugs (for example diazepam or tramadol) are
More informationThe Neurobiology of Drug Addiction
National Institute on Drug Abuse (NIDA) The Neurobiology of Drug Addiction Last Updated January 2007 https://www.drugabuse.gov 1 Table of Contents The Neurobiology of Drug Addiction Section I: Introduction
More informationDiscover the Hope: Opiate Treatment and Recovery
Discover the Hope: Opiate Treatment and Recovery The Continued Struggle to Find and Implement Best Practices Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of
More informationIt is a pleasure and an honor for me to deliver this year s
HENRY WAGNER LECTURESHIP Imaging the Addicted Brain: From Molecules to Behavior Nora Volkow, MD, Director of the National Institute on Drug Abuse, delivered the Henry Wagner lecture at a plenary session
More informationThe Impact of Research on the Care of Addicted Patients. Update. Nora D. Volkow, M.D. Director National Institute on Drug Abuse
The Impact of Research on the Care of Addicted Patients A Update Nora D. Volkow, M.D. Director National Institute on Drug Abuse HISTORY - previous history - expectation - learning DRUGS BIOLOGY - genetics
More informationBarriers to recovery for Buprenorphine Patients in Bangor, Maine
University of Vermont ScholarWorks @ UVM Family Medicine Block Clerkship, Student Projects College of Medicine 15 Barriers to recovery for Buprenorphine Patients in Bangor, Maine Erin L. Keller University
More informationPregnancy, MAT and Addiction
Pregnancy, MAT and Addiction Carl Christensen, MD, PhD, D-FASAM Clinical Associate Professor, OB Gyn & Psychiatry Wayne State University School of Medicine William Morrone, DO, MPH, DABAM Covenant Hospital
More informationOpioid Overdose Epidemic A Crises and Opportunity
Opioid Overdose Epidemic A Crises and Opportunity Samuel M. Silverman MD, FAPA, DFASAM Assistant Clinical Professor, UConn Medical School Director, Medical Education Rushford, A Hartford HealthCare Partner
More informationIf you give any person a prescription of something like Valium and have them take it on
As always I am happy to do this presentation, which is my favorite topic in addiction medicine. I am an internist, and I have done healthcare for the homeless in Springfield as well as been the medical
More informationUnderstanding the Brain: What Drugs Can Tell Us
LIVE INTERACTIVE LEARNING @ YOUR DESKTOP Understanding the Brain: What Drugs Can Tell Us Presented by: Dr. Rochelle D. Schwartz-Bloom March 24, 2011 Understanding the Brain: What Drugs Can Tell Us Rochelle
More informationPrescription Opioids
What are prescription opioids? Prescription Opioids Opioids are a class of drugs naturally found in the opium poppy plant. Some prescription opioids are made from the plant directly, and others are made
More informationWhat Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016
What Science Says about Opioid Use Disorder and Its Treatment Perilou Goddard, Ph.D. Department of Psychological Science Northern Kentucky University Examples of Opioids Agonists (activate opioid receptors)
More informationComprehensive Smoking Cessation Programs
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/comprehensive-smokingcessation-programs/3403/
More informationWhat would it take to get to zero overdose deaths in California? Kelly Pfeifer, MD May 5, 2017
What would it take to get to zero overdose deaths in California? Kelly Pfeifer, MD kpfeifer@chcf.org May 5, 2017 Beth Name and picture changed What we believed then Opioids are safer than alternatives
More informationAddiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer
Addiction to Opioids Marvin D. Seppala, MD Chief Medical Officer Mayo Clinic Opioid Conference: Evidence, Clinical Considerations and Best Practice Friday, September 30, 2016 26 y.o. female from South
More informationPatient Information Leaflet
Page 25 Patient Information Leaflet PATIENT INFORMATION SUBOXONE (sub-ox-own) (buprenorphine HCl/naloxone HCl dihydrate, sublingual tablet) (C*) SUBUTEX (SUB-u-tex) (buprenorphine HCl, sublingual tablet)
More informationAddiction. Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine
Addiction Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine Twitter: @rcwallermd Objectives Understand the Concept of Addiction Survival FOOD WATER DOPAMINE
More informationPRESCRIBING OPIATES IN CONTEXT OF OPIATE USE DISORDER
PRESCRIBING OPIATES IN CONTEXT OF OPIATE USE DISORDER Ken Hopper, MD, MBA Health Strategies and Population Health TCU/UNTHSC School of Medicine The Hopper Group-Fort Worth, Arlington, Dallas MAKING IT
More informationNoel Schenk MD. Davis Behavioral Health
Noel Schenk MD Davis Behavioral Health Michael Botticelli Director of National Drug Control Policy What is Addiction? Addiction is defined as a chronic, relapsing brain disease that is characterized by
More informationCONCERNED ABOUT TAKING OPIOIDS AFTER SURGERY?
CONCERNED ABOUT TAKING OPIOIDS AFTER SURGERY? ASK YOUR DOCTOR ABOUT EXPAREL FOR LONG-LASTING, NON-OPIOID PAIN RELIEF. VISIT EXPAREL.com/patient FOR MORE INFORMATION. YOU HAVE A SAY IN HOW YOUR PAIN IS
More information8/5/2013. MOSBIRT Annual Training The Big change in addiction medicine? Before we dive into pharmacotherapy
Medication Assisted Treatment for Substance Abuse in Primary Care Dan Vinson August 1, 2013 1 The Big change in addiction medicine? These diseases are rapidly becoming medical diseases. Done are the days
More informationOpioid Review and MAT Clinic CDC Guidelines
1 Opioid Review and MAT Clinic CDC Guidelines January 10, 2018 Housekeeping Use chat feature to inform everyone who s at your clinic Click chat on Zoom option bar Chat Everyone the names of those who are
More informationHistory Of Medical Cannabis
History Of Medical Cannabis Historical and archaeological evidence of widespread use in ancient times as medicine, food, textiles & for sacraments, rituals Possibly first domesticated crop Introduction
More informationMethods for Identifying Street & Prescription Drug Abuse
Methods for Identifying Street & Prescription Drug Abuse presented by Sharon S. Kelley, MS, PhD Chief Executive Officer Associates In Emergency Medical Education, Inc. Alliance for Global Narcotics Training,
More informationNational Academies of Sciences, Engineering, and Medicine Forum on Neuroscience and Nervous System Disorders
National Academies of Sciences, Engineering, and Medicine Forum on Neuroscience and Nervous System Disorders Workshop: Advancing Therapeutic Development for Pain and Opioid Use Disorders through Public-Private
More informationAddiction in the Brain - Latest Research. Gary M. Henschen, MD, LFAPA Chief Behavioral Health Officer Magellan Healthcare, Inc.
Addiction in the Brain - Latest Research Gary M. Henschen, MD, LFAPA Chief Behavioral Health Officer Magellan Healthcare, Inc. The Neurobiology of Addiction About the speaker Gary M. Henschen, M.D. is
More informationLatest Press Release. How much for 30 mg adderall
corp@stantec.com Latest Press Release How much for 30 mg adderall S 14-2-2008 Hi my name is Rachel i have been on suboxone for almost a year as of OCT 1st, and I have become the person I guess I am to
More informationNURSING INTAKE. Provider Name: Provider Signature: Nursing Summary. Are you pregnant at this time?
NURSING INTAKE Provider Name: Provider Signature: Date: Nursing Summary Are you pregnant at this time? 3 = Don t know 4 = Tubal ligation 5 = Menopause 6 = History of hysterectomy 7 = Other: 8 = N/A patient
More informationH NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher.
H NDS-ONHealth Health Wave Newsletter, October 2013 Visit us on our website at www.healthwaveinc.com Drug overdose death rates in the United States have more than tripled since 1990 and have never been
More informationIt s Not Just Drug Addiction! Howard Wetsman MD DFASAM Chief Medical Officer Townsend Treatment
It s Not Just Drug Addiction! Howard Wetsman MD DFASAM Chief Medical Officer Townsend Treatment Centers @addictiondocmd hwetsman@contactaac.com Let s Start With Why What I want Can it happen? We Don t
More informationWelcome to the Opioid Overdose Prevention Project
Welcome to the Opioid Overdose Prevention Project Narcan Training TODAY S OBJECTIVES Define drug addiction Identify symptoms of addiction Treatment options including support for family members How to recognize
More information